Acquired inflammatory demyelinating neuropathies.
The acquired demyelinating neuropathies can be divided into those with an acute onset and course and those with a more chronic course. The acute neuropathies present as Guillain-Barré syndrome and include acute inflammatory demyelinating polyradiculoneuropathy (AIDP), Miller Fisher syndrome, acute motor axonal neuropathy (AMAN), acute motor and sensory axonal neuropathy (AMSAN), and acute pandysautonomia. The chronic neuropathies are collectively known as chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and include MADSAM (multifocal acquired demyelinating sensory and motor neuropathy, also know as Lewis-Sumner syndrome) and DADS (distal acquired demyelinating symmetric neuropathy) as variants. The clinical features, pathology, pathogenesis, diagnosis, treatment, rehabilitation, and prognosis of these neuropathies are discussed.
Ensrud
E R
ER
Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Krivickas
L S
LS
D000208:Acute Disease; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004594:Electrophysiology; D020275:Guillain-Barre Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000534:rehabilitation*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D010951:Plasma Exchange / Q000379:methods; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000175:diagnosis* / Q000188:drug therapy / Q000534:rehabilitation*; D011379:Prognosis
D016756:Immunoglobulins, Intravenous